Last week, the major U.S. indexes ended narrowly mixed. The Nasdaq added 1.1%, the NYSE composite rose 0.6%, the S&P 500 inched up 0.1%, and the Dow faded 0.5%. The IBD outlook remains at “confirmed uptrend”. The market rally is in good shape with a minimum of distribution days so far, the trend is your friend. However, the market has moved a long way in a short period of time, a consolidation or profit taking wouldn’t be at all surprising. It’s still a green light for making new purchases, just make sure you’re only buying quality stocks at proper buy points.

This week, three watch list stocks are at or near proper buy points. ULTA, trading at $77.31, broke out of a 4th stage cup base on low volume and still within 5% of a $75.80 buy point. ULTA has had a long run and this is a late stage base, insist on seeing some good upside volume before wading in. DLTR, trading at $84.64, is still just above a $84.09 buy point off of a three weeks tight pattern. DG, trading at $42.09, broke out of a 2nd stage flat base on good volume and has settled back to just below a $42.20 buy point.

Last week, the major U.S. indexes continued their steady melt up. The Nasdaq gained 2.8%, the NYSE composite rose 2.6%, the Dow moved up 2.4%, and the S&P 500 added 2%. The IBD outlook remains at “confirmed uptrend”. Earnings season rolls on as European fears appear to have faded, for now.

This week, five watch list stocks are at or near proper buy points. ULTA, trading at $76.26, broke out of a 4th stage cup base on low volume and is just above a $75.80 buy point. ALXN, trading at $73.58, is still within 5% of a $70.52 buy point from a 4th stage flat base. DLTR, trading at $84.46, moved past a three weeks tight pattern and is just above a $84.09 buy point. DG, trading at $40.96, found support at its 10 week line and is in buying range up to $44.20. TSCO, trading at $79.99, broke out of a 1st stage flat base and is still within 5% of a $78.32 buy point.

Last week, the major U.S. indexes moved higher once again. The Nasdaq gained 1.4%, the NYSE composite rose 1%, the S&P 500 added 0.9%, and the Dow moved up 0.5%. The IBD outlook remains at “confirmed uptrend”. Earnings season picks up steam this week while European downgrades loom large, which will the markets follow?

This week, five watch list stocks are at or near proper buy points. LQDT, trading at $36.68, is still within 5% of a $36.22 buy point. DLTR, trading at $82.75, has shown four weeks of tight closes and is just past a $82.59 buy point. TSCO, trading at $80.59, is still within 5% of a $78.32 buy point. DG, trading at $41.00, is just past a $40.81 buy point. AAP, trading at $71.46, is just above a $71.10 buy point.

Last week, the major U.S. indexes moved higher. The Nasdaq gained 2.7%, the S&P 500 added 1.6%, the Dow rose 1.2%, and the NYSE composite tacked on 1.1%. The IBD outlook remains at “confirmed uptrend”. Earnings season starts this week, so pay attention, volatility could pick up.

This week, three watch list stocks are at or near proper buy points. LQDT, trading at $37.32, is still within 5% of a $36.22 buy point. DG, trading at $40.87, is just past a $40.81 buy point. AAP, trading at $71.50, is just above a $71.10 buy point.

Last week, the major U.S. indexes edged lower. The Nasdaq gave up 0.5% and The NYSE composite, S&P 500 and the Dow each lost 0.6%. The IBD outlook remains at “confirmed uptrend”. Let’s hope this year is better than the last one.

This week, four watch list stocks are at or near proper buy points. LQDT, trading at $36.90, is still within 5% of a $36.22 buy point. ALXN, trading at $71.50, is just above a $70.42 buy point. MA, trading at $372.82, is still within 5% of a $362.04 buy point. DG, trading at $41.14, is just past a $40.81 buy point.